Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A Novel PD-L1 Antibody Promotes Antitumor Function of Peripheral Cytotoxic Lymphocytes after Radical Nephrectomy in Patients with Renal Cell Carcinoma

The Journal of Immunology(2023)10.4049/jimmunol.2200933Source: DataRank Database

A Novel PD-L1 Antibody Promotes Antitumor Function of Peripheral Cytotoxic Lymphocytes after Radical Nephrectomy in Patients with Renal Cell Carcinoma is a research paper published in The Journal of Immunology (2023). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

Linked data & code

gen

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.58)OA: bronzeTopics (28)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (16)

Michelle A. Hsu ORCID,Joanina K. Gicobi ORCID,Tianxiao Xu ORCID,Susan M. Harrington ORCID,Henan Zhang ORCID

Live enrichment

PubMed:37163328 PMC:PMC10615852 OpenAlex:https://openalex.org/W4376118539

HHS | NIH | National Cancer Institute

Grant: R01CA256927

HHS | NIH | National Institute of Allergy and Infectious Diseases

Grant: R01AI095239

FWCI

0.58

Citation Percentile

0.7%

Citation Trend

2025

bronzeLicense: https://academic.oup.com/pages/standard-publication-reuse-rights

journalhttps://journals.aai.org/jimmunol/article-pdf/210/12/2029/1645790/ji2200933.pdf

publisherhttps://journals.aai.org/jimmunol/article-pdf/210/12/2029/1645790/ji2200933.pdf

publisherhttps://academic.oup.com/jimmunol/article-pdf/210/12/2029/61470062/ji2200933.pdf

journalhttps://doi.org/10.4049/jimmunol.2200933

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37163328

Fields of Study

Cancer Immunotherapy and BiomarkersRenal cell carcinoma treatmentCAR-T cell therapy research

MeSH Terms

Immune Checkpoint InhibitorsAntineoplastic AgentsCarcinoma, Renal CellHumansKidney NeoplasmsLeukocytes, MononuclearNephrectomyCD8-Positive T-LymphocytesT-Lymphocytes, RegulatoryB7-H1 AntigenProgrammed Cell Death 1 Receptor

Keywords

Cytotoxic T cellRenal cell carcinomaNephrectomyMedicineAntibodyCancer researchPeripheralUrologyImmunologyInternal medicineChemistryKidneyIn vitroBiochemistry

Sustainable Development Goals

SDG 0: Good health and well-being

A Novel PD-L1 Antibody Promotes Antitumor Function of Peripheral Cytotoxic Lymphocytes after Radical Nephrectomy in Patients with Renal Cell Carcinoma

FAIR Checklist

Authors (16)

Funding (2 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)